Epidemiology of cryptococcosis in France: A 9-year survey (1985-1993)

Clinical Infectious Diseases

Volumn 23, Issue 1, 1996, Pages 82-90

  Dromier, Françoise ^b   Mathoulin, Simone ^a   Dupont, Bertrand ^c   Laporte, Anne ^c  

^a UFR de Santé Publique   (France)

^b INSTITUT PASTEUR   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CORTICOSTEROID THERAPY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; FRANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MENINGITIS; PRIORITY JOURNAL; SEROTYPING;

EID: 0029839019     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.1.82     Document Type: Article

References (17)

1. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993;17:837-42.
2. Kvvon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE, eds. Medical mycology. Philadelphia: Lea & Febiger, 1992:397-446.
3. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995;8:515-48.
4. Liftman ML, Walter JE. Cryptococcosis: current status. Am J Med 1968;45:922-32.
5. Dismukes WE. Cryptococeal meningitis in patients with AIDS. J Infect Dis 1988;157:624-8.
6. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl 1):1S-15S.
7. Knight FR, Mackenzie DW, Evans BG, Porter K, Barren NJ, White GC. Increasing incidence of Cryptococcosis in the United Kingdom. J Infect 1993;27:185-91.
8. Réseau National de Santé Publique. Surveillance du SIDA en France (situation au 30 juin 1994). Bulletin Epidémiologique Hebdomadaire 1994;32:65-71.
9. 3. J Infect Dis 1994;170:1284-7.
10. Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:533-8.
11. Clumeck N, Carael N, Van de Perre P. The African AIDS experience in contrast with the rest of the world. In: Leong G, Mills J, eds. Opportunistic infections in patients with the acquired immunodeficiency syndrome. New York: Marcel Dekker, 1989:43-56.
12. Dromer F, Salamero J, Contrepois A, Carbon C, Yeni P. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryplococcus neoformans capsular polysaccharide. Infect Immun 1987;55:742-8.
13. Dromer F, Guého E, Ronin O, Dupont B. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J Clin Microbiol 1993;31:359-63.
14. Hubert B, Desenclos JC. Evaluation de l'exhaustivité et de la représentativité d'un système de surveillance par la méthode de capture-recapture. Application à la surveillance des infections à méningocoque en France en 1989 et 1990. Rev Epidemiol Santé Publique 1993;41:241-9.
15. Sekar CC, Deming WE. On a method of estimating birth and death rates and the extent of registration. Am Stat Assoc J 1949;44:100-15.
16. International Working Group for Disease Monitoring and Forecasting. Capture-recapture and multiple-record systems estimation II: application in human diseases. Am J Epidemiol 1995;142:1059-68.
17. Jowitt SN, Love EM, Yin JA, Pumphrey RS. CD4 lymphocytopenia without HIV in patient with cryptococcal infection [letter]. Lancet 1991;337:500-1.